1643.HK Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 09:38):
Our systems believe the stock currently is overvalued by -0.03% compare to its pairs and should correct downwards.

Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China...

Stats
Tagesvolumen	27 000
Durchschnittsvolumen	226 406
Marktkapitalisierung	240.00M
EPS	HKD0.0382 ( Q4 \| 2023-12-31 )
Last Dividend	HKD0.0167 ( 2022-05-25 )
Next Dividend	HKD0 ( N/A )
P/E	4.44 (Sector) 14.27 (Industry) 0
ATR14	HKD0 (0.00%)

1093.HK -1.74%

1643.HK 8.11%

1666.HK 1.61%

3933.HK -0.24%

Korrelation (AI algo v.1.1b): Overvalued: -0.03% HKD0.400 paired level. (Der Algorithmus verfolgt in Echtzeit die Änderungen der am stärksten korrelierten Aktien und gibt eine sofortige Aktualisierung)

Modern Chinese Medicine Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Modern Chinese Medicine Finanzdaten

Annual	2023
Umsatz:	HKD344.08M
Bruttogewinn:	HKD104.18M (30.28 %)
EPS:	HKD0.0813

FY	2023
Umsatz:	HKD344.08M
Bruttogewinn:	HKD104.18M (30.28 %)
EPS:	HKD0.0813

FY	2022
Umsatz:	HKD399.66M
Bruttogewinn:	HKD170.79M (42.73 %)
EPS:	HKD0.150

Financial Reports:

No articles found.

Modern Chinese Medicine Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Modern Chinese Medicine Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.59 - Potential for dividend initiation, but uncertain (11.83%)

Information

First Dividend	HKD0.0167	2022-05-25
Last Dividend	HKD0.0167	2022-05-25
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	HKD0.0167	--
Avg. Dividend % Per Year	0.00%	--
Score	2.93	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.59
Div. Directional Score	9.74	--

Next Divdend (Est)
(2024-06-30)

HKD0 Estimate 0.00 %

Dividend Stability

0.03 Very Bad

Dividend Score

2.93

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
25 May 2022	HKD0.0167	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
1598.HK	Ex Dividend Junior	2023-07-13	Annually	0.00%
0057.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
6826.HK	Ex Dividend Knight	2023-07-04	Annually	0.00%
1066.HK	Ex Dividend Knight	2023-10-19	Semi-Annually	0.00%
2360.HK	Ex Dividend Knight	2023-10-03	Annually	0.00%
0636.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
1857.HK	Ex Dividend Junior	2023-08-23	Semi-Annually	0.00%
0217.HK	Ex Dividend Junior	2023-07-05	Sporadic	0.00%
1286.HK	Ex Dividend Knight	2023-08-21	Semi-Annually	0.00%
3718.HK	Ex Dividend Knight	2023-09-11	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.159	1.500	6.83	10.00	[0 - 0.5]
returnOnAssetsTTM	0.183	1.200	3.90	4.69	[0 - 0.3]
returnOnEquityTTM	0.209	1.500	8.79	10.00	[0.1 - 1]
payoutRatioTTM	0.00736	-1.000	9.93	-9.93	[0 - 1]
currentRatioTTM	8.93	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.96	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	5.86	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.000136	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	9 967.60	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.135	2.00	9.95	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.113	2.00	9.94	10.00	[0 - 20]
debtEquityRatioTTM	0.000152	-1.500	10.00	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.344	1.000	7.60	7.60	[0.2 - 0.8]
operatingProfitMarginTTM	0.239	1.000	7.23	7.23	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1 126.05	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.153	0.800	5.65	4.52	[0.5 - 2]
Total Score				13.90

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	2.48	1.000	9.85	0	[1 - 100]
returnOnEquityTTM	0.209	2.50	9.22	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.113	2.00	9.96	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.135	2.00	9.95	10.00	[0 - 30]
payoutRatioTTM	0.00736	1.500	9.93	-9.93	[0 - 1]
pegRatioTTM	0.189	1.500	-2.07	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.133	1.000	9.17	0	[0.1 - 0.5]
Total Score				5.59

Modern Chinese Medicine Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Modern Chinese Medicine

Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China. It offers therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, respiratory system, and nervous system conditions. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. is a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.